Thermo Fisher Scientific Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 43 Posts
1 2 3
Thermo Fisher Acquires Qiagen For EUR 39 Per Share In Cash Or $11.5B
Article By: The Fly Tuesday, March 3, 2020 5:52 AM EDT
Thermo Fisher Scientific and Qiagen announced that their boards have unanimously approved Thermo Fisher's proposal to acquire Qiagen for EUR 39 per share in cash.
In this article: TMO, QGEN
Read
Healthcare (Top 30 Weights) Earnings Estimates And Revisions
Article By: T.J. Hayes Monday, February 17, 2020 5:44 AM EDT
The cumulative 2020 earnings power of these 30 stocks was revised down by -.34% in the past 60 days.
In this article: EW, HCA, HUM, JNJ, LLY, MDT, MRK, PFE, SYK, TMO, UNH, ILMN, AMGN, BIIB, GILD, ISRG, VRTX Also: ABT, AGN, BAX, BDX, BMY, BSX, CI, CNC, CVS, DHR, XLV, ZTS, ABBV, ANTM
Read
Week In Review: Suzhou's Ascentage Pharma Stages $53 Million IPO In Hong Kong
Article By: ChinaBio® Today Saturday, October 26, 2019 9:04 PM EDT
Deals, financings, trials and approvals, and other company news for Chinese companies involved in global biotech.
In this article: MRK, TMO, TLC
Read
Top Five Weekend Stock Stories - Jan. 20
Article By: The Fly Sunday, January 20, 2019 4:13 PM EDT
Catch up on the weekend's top five stories with this list compiled by The Fly.
In this article: ZNTVI, A, DHR, EA, KRC, NEM, TMO, VNO, OPCO, TCEHY, ILMN, LOOP, AMZN, ATVI, CMCSA, CMCSK, COST, GOLD, NFLX, TECH, TSLA
Read
5 Cheap PEG Stocks Suitable For GARP Investors
Article By: Zacks Investment Research Thursday, August 2, 2018 1:12 PM EDT
Investors seeking long-term growth often wonder whether they should resort to any of the fundamental strategies like growth or value. Going by Warren Buffett, these two approaches are joined at the hip.
In this article: HCA, TMO, BIIB, GILD, QCOM
Read
S&P 500 Nears 2,500: 5 Stock Picks For Big Profits
Article By: Swarup Gupta Thursday, September 14, 2017 12:32 PM EDT
The U.S. market’s broadest benchmark homed in on the crucial 2,500 mark during a relatively quiet session of trading. This was the second successive record close for the S&P 500, a feat matched by the two other primary gauges of market performance.
In this article: BA, CAT, EL, TSS, TMO Also: SPX
Read
Thermo Fisher Acquires Patheon, Boosts Laboratory Products
Article By: Zacks Investment Research Wednesday, August 30, 2017 12:27 PM EDT
Thermo Fisher Scientific Inc. recently completed the buyout of Patheon N.V. Notably. Over the past three months, Thermo Fisher has been trading above the broader industry.
In this article: TMO Also: EW, IDXX, LNTH
Read
Seeking Confirmations – US Stock Market
Article By: Gary Tanashian Sunday, August 20, 2017 5:40 PM EDT
We have several inputs forecasting change (market pivots) ranging from seasonal tendencies to an expected US dollar rally, Fed monetary tightening, the 30 month S&P 500 cycle, not to mention a presidential administration in utter disarray.
In this article: MDT, TMO, IBB, GLD, IHI, XLV, SPX
Read
The S&P 500 And The Nasdaq Hit Record Highs Today
Article By: Marvin R Clark Monday, May 15, 2017 11:23 PM EDT
The S&P 500 and the Nasdaq hit record highs today. Profits from S&P 500 companies surged by 14.9% during the first quarter, the fastest rate since 2011. That’s a far cry from the earnings decline of nearly 7% experienced at the start of 2015.
In this article: CVX, M, TMO, WFC, XOM, AMZN, GOOGL, PTHN
Read
Thermo Fisher Scientific Inc. Announces Acquisition Of Patheon NV For $7.2 Billion
Article By: Lorimer Wilson Monday, May 15, 2017 2:35 PM EDT
Patheon NV shares were jumping higher on Monday morning, following news that the drug ingredients maker would be acquired by Thermo Fisher Scientific Inc.
In this article: TMO, PTHN
Read
Trump, Biogen And Amgen Hammer Healthcare ETFs
Article By: Sweta Killa Monday, March 20, 2017 2:05 PM EDT
The initial sell-off came after Trump’s budget blueprint, which signaled higher regulatory costs for the sector and a cut in federal funding for medical research.
In this article: BIIB, AMG, PFE, CELG, ABT, TMO Also: ESPR, MDCO, BBH, IBB, BBP, XLV, VHT, IYH
Read
Thermo Fisher (TMO): Tops Q4 Earnings, Misses Revenues
Article By: Zacks Investment Research Tuesday, January 31, 2017 10:23 AM EDT
Thermo Fisher posted revenues of $4,953.2 billion, including $1.34 billion (up 10%) in Life Sciences Solutions, and $1.22 billion (up 32%) in Analytical Instruments.
In this article: TMO
Read
8 Best Stocks For Value Investors Of The Week – 12/10/16
Article By: Benjamin Clark Saturday, December 10, 2016 5:40 PM EDT
I evaluated 42 different companies to determine if they're suitable for Defensive Investors, unwilling to do substantial research, or Enterprising Investors, those willing to do research. Out of the 42 companies, only 8 were found to be undervalued.
In this article: SAM, TMO, TRV, WHR, CFP, SANM, FOXA, SBRA
Read
7 Dividend Stocks That Promise Stability And Growth
Article By: Sweta Killa Friday, October 28, 2016 1:21 PM EDT
Ahead of the presidential elections, dividend investing is again in vogue. Here are seven of the 17 stocks that fit the bill.
In this article: ATVI, INTC, PKG, TMO, DKS, GNTX, RSG
Read
Illumina Misses Revenue Forecast Causing Collateral Damage To Biotechs
Article By: Rod Raynovich Tuesday, October 11, 2016 11:00 PM EDT
Illumina shares crashed 25% to $139, after a warning on third quarter sales. The global leader in DNA sequencing systems warned that revenues missed forecast and would be $607M, well short of earlier guidance of $625-$630M.
In this article: TMO, RHHBY, IBB, ILMN, PACB, QGEN, XBI, XLV, FMI
Read
Rayno 2016 Life Science Portfolio Update
Article By: Rod Raynovich Thursday, September 29, 2016 8:14 PM EDT
Biotech stocks are near their intermediate highs but still down in 2016 : IBB at $295 down 12.78% and the XBI​ at $67.80 down 3.42% YTD.
In this article: ALR, BMY, TMO, RHHBY, CPHD, IBB, ILMN, AMGN, GILD, XBI, ABBV, BLUE, FMI
Read
1 to 16 of 43 Posts
1 2 3